Investigating a Natural Antioxidant Food Product on Oxidative Stress in Recreationally Active Participants

Oxidative Stress Clinical Trial

Official title:

Investigating the Impact of a Natural Antioxidant Food Product on Exerciseinduced Oxidative Stress in Recreationally Active Participants

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04959006
• Other study ID #: R9039
• Status: Completed
• Phase: N/A
• Start date: May 1, 2021
• Est. completion date: October 1, 2021

Study information

• Verified date: February 2022
• Source: Anglia Ruskin University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of this study is to investigate the short term use of olive extract polyphenols on markers of oxidative stress in response to acute endurance exercise in recreationally active, healthy volunteers.The study will be conducted under laboratory conditions following a 16 day supplemental period. Participants will be required to attend the laboratory for a pre-screening/familiarisation trial followed by assessments PRE (baseline, days 1,2) and POST intervention (days 18,19). Across the intervention, participants will maintain habitual dietary intake/ exercise training.

Additionally participants will be randomised in a double-blinded manner to either a placebo or antioxidant-rich supplementation (olive extract water).

It is hypothesised that the polyphenols (antioxidants) found within olive extract drink will enhance markers of recovery to an endurance exercise bout compared with the placebo drink.

Description:

There is current scientific interest in the use of fruit and plant-based polyphenol supplementation for exercise recovery. Current inference highlights that acute supplementation (~3d) with >1000mg polyphenols per day may enhance recovery from intensive exercise, with most focus on pomegranate, cocoa, green tea extracts, Montmorency cherry concentrate and blackcurrant food products. However, further research is needed to access impact of natural polyphenols at lower or similar doses for longer time periods (>7d) on endurance based activities and subsequent recovery.

There has also been significant clinical research interest in the properties of waste water produced when cold pressing olives, which has been shown to contain high concentrations of natural polyphenols. Fattoria La Vialla is an Italian-based organic farm producing various products including cold-pressed olive oil. In doing so, they also produce olive extract which is commercially available as 'Oliphenolia'. Whilst several clinical studies have been undertaken using this product, to date there have been no studies investigating the polyphenol potential of olive extract on exercise recovery and subsequent performance.

As such, this study proposes to investigate the short term use of olive extract polyphenols on markers of oxidative stress in response to acute endurance exercise in recreationally active, healthy volunteers. Following a study briefing and provision of written, informed consent, participants will be required to attend the Human Physiology Laboratory at Anglia Ruskin University on 5 occasions as follows:

Session 1 - assessment of metabolic responses to incremental exercise intensity and individual maximal oxygen uptake (VO2max) using a standardised treadmill-based ramp protocol. Measurement of VO2max will be required for assessment of exercise intensity for sessions 2 and 4 (see below). The treadmill protocol to be used is similar to that previously published, involving two graded exercise tests (GXT1 and GXT2). Following a 10min resting period and assessment of baseline measures (e.g. blood pressure, body composition) and a 5min warm up period, GXT1 will involve participants completing ~6 x 4min stages (3mins running, 1 minute passive recovery in which capillary blood sampling for glucose/lactate will be carried out). Starting speeds will be between ~6-10km/h (1 % gradient) with each stage involving speed increments of 1 km/h. Exercise will continue until blood lactate concentration exceeds 4 mMol/L. Following a 10 min rest, GXT 2 will begin at a speed 2 km·h-1 below the previous GXT 1 final speed, with gradient increasing by 1 % each min and continuing until volitional exhaustion. Throughout the test, breath-to-breath analysis (using a Metalyser 3B respiratory analyser) will be undertaken.

Session 2 - Having overnight fasted, and following resting measures (blood pressure, body composition via bioelectrical impedance analysis, 3x4ml blood sample), participants will complete an endurance training session (~75% VO2max for 60mins) on a treadmill. Additional wholeblood samples (3x4ml) will be collected immediately and 1hr post exercise.

Session 3 - Participants will return the next morning (overnight fasted) for a resting blood sample (3x4ml, 24 hours post exercise) and complete the same GXT1 and GXT2 tests carried out in session 1. This will be used to quantify metabolic and recovery indices.

Session 4 and 5 - following a 16 day nutrition product supplementation period, participants will return and complete exercise testing as per sessions 2 and 3.

Nutritional supplementation - all products will be supplied/certified independently via Fattoria La Vialla, Italy. Participants will be randomly assigned in a double-blinded manner to either: i) Experimental condition: 2x25ml olive extract drinks (https://www.oliphenolia.it/uk/) per day for 16 days, taken one mid-morning, one mid-afternoon between meals or ii) matched placebo (2x25ml of prune juice water).

Blood samples - wholeblood samples will be immediately centrifuged with serum allocated into separate cryovials for the analysis of: i) the main polyphenol compound- hydroxytyrosol; ii) a marker of oxidative stress (malondialdehyde, MDA) and iii) key antioxidant enzymes (catalase, superoxide dismutase) and redox status (reduced glutathione (GSH) to oxidized glutathione (GSSG) ratio).

Over the 16 day study period, there will be no dietary restrictions in place (other than following a low polyphenol diet 24 hours prior to each testing session), however participants will need to follow the allocated supplementation and maintain their training program (~3-4 run training sessions per week).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: October 1, 2021
• Est. primary completion date: September 1, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 21 Years to 65 Years

Eligibility

Inclusion Criteria:

• Men and women, UK based, above 21 years of age and below 65 years of age

• All participants: No known history (including family history) of heart abnormalities, hypertension, coronary heart disease or diabetes (determined from pre-study health screen questionnaire)

• All participants: Not currently suffering from any musculo-skeletal injury, or any other reason that may prevent participation in cardiovascular exercise

• All participants: Have not suffered from recent viral infections ie: influenza (defined within the prior 2 months)

• All participants (and household members): COVID-19 related - have not suffered with any symptoms associated with Covid-19

• All participants: Not suffering from any known blood related disorders, including blood coagulation abnormalities, or have any adverse reactions to blood taking

• All participants: Not taking any prescribed or over-the-counter medication which may influence exercise training (with the exception of inhalers for exercise induced asthma or contraceptive pill)

• All participants: Not consuming or prepared to refrain from consumption, any commercial supplementation which conflicts with the study parameters ie: antioxidants.

• All participants: no known allergy or intolerance to olives or prune/grape juice.

• Baseline maximal oxygen uptake >25ml/kg/min representative of normal fitness levels (measured during pre-screening)

Exclusion Criteria:

• Anyone below the age of 21 years or above 65 years of age

• All participants: anyone with a known history (including family history) of heart abnormalities, hypertension, coronary heart disease or diabetes (determined from pre-study health screen questionnaire)

• All participants: Anyone suffering from a current musculo-skeletal injury, or any other reason that may prevent participation in cardiovascular exercise

• All participants: those suffering from recent viral infections ie: influenza (defined within the prior 2 months)

• All participants: anyone who has (previously or currently) had any symptoms associated with covid-19 (including household members)

• All participants: Those with known blood related disorders, including blood coagulation abnormalities, or have any adverse reactions to blood taking. This includes any participant who has or potentially has an infectious disease, inc. HIV, and all types of hepatitis.

• All participants: Anyone taking any prescribed or over-the-counter medication which may influence exercise training (with the exception of inhalers for exercise induced asthma or contraceptive pill)

• All participants: Anyone consuming or not prepared to refrain from consumption, any commercial supplementation which conflicts with the study parameters ie: antioxidants

• All participants: anyone with a known allergy or intolerance to olives or prune/grape juice.

• Any not meeting the baseline criteria for maximal oxygen uptake

• FEMALE ONLY: Any participant who is, suspects they may be or becomes pregnant during the study.

Related Conditions & MeSH terms

• Exercise Recovery
• Oxidative Stress

Intervention

Dietary Supplement:
• Antioxidant supplement
Short term (16d) supplementation of either the antioxidant supplement (Oliphenolia) or placebo. Participants required to consume 2x25ml drinks, one mid-morning, one mid-afternoon between meals.
• Placebo
Placebo

Locations

Country	Name	City	State
United Kingdom	Anglia Ruskin University	Cambridge	Cambridgeshire

Sponsors (1)

Lead Sponsor	Collaborator
Anglia Ruskin University

Country where clinical trial is conducted

United Kingdom, 

References & Publications (4)

Bloomer RJ, Goldfarb AH, McKenzie MJ. Oxidative stress response to aerobic exercise: comparison of antioxidant supplements. Med Sci Sports Exerc. 2006 Jun;38(6):1098-105. — View Citation

Bowtell J, Kelly V. Fruit-Derived Polyphenol Supplementation for Athlete Recovery and Performance. Sports Med. 2019 Feb;49(Suppl 1):3-23. doi: 10.1007/s40279-018-0998-x. Review. — View Citation

Fisher-Wellman K, Bloomer RJ. Acute exercise and oxidative stress: a 30 year history. Dyn Med. 2009 Jan 13;8:1. doi: 10.1186/1476-5918-8-1. — View Citation

James CA, Richardson AJ, Watt PW, Gibson OR, Maxwell NS. Physiological responses to incremental exercise in the heat following internal and external precooling. Scand J Med Sci Sports. 2015 Jun;25 Suppl 1:190-9. doi: 10.1111/sms.12376. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Oxidative stress biomarker	Blood measure of malondialdehyde, MDA (pmol/ml)	Change from pre (day 1) to post intervention (day 18)
Primary	Redox status	Blood measure of reduced glutathione (GSH) to oxidized glutathione (GSSG) (measured in uM)	Relative change from pre (day 1) to post intervention (day 18)
Primary	Endogenous antioxidant enzyme 1	Blood measure of catalase (mU/ml)	Relative change from pre (day 1) to post intervention (day 18)
Primary	Endogenous antioxidant enzyme 2	Blood measure of superoxide dismutase (inhibition rate %)	Relative change from pre (day 1) to post intervention (day 18)
Primary	Hydroxytyrosol	Blood measure of hydroxytyrosol (main active ingredient in the antioxidant supplementation, measured in ng/ml)	Overall change from pre (day 1) to post intervention (day 18)
Secondary	Submaximal exercise respiratory measures	Assessment of metabolic efficiency via respiratory measures (oxygen, carbon dioxide, both measured in L/min) during steady state exercise	Relative change from pre (day 1) to post intervention (day 18)
Secondary	Maximal exercise respiratory measures	Assessment of exercise capacity and tolerance during maximal exercise via respiratory measures (oxygen, carbon dioxide, both measured in L/min)	Relative change from pre (day 1) to post intervention (day 18)
Secondary	Body mass	Assessment of body mass (kg). Body mass and height will be combined to report Body Mass Index (BMI) in kg/m^2	Change from pre (day 1) to post intervention (day 18)
Secondary	Height	Assessment of participant height (m). Body mass and height will be combined to report Body Mass Index (BMI) in kg/m^2	Change from pre (day 1) to post intervention (day 18)
Secondary	Body composition	Assessment of bodyfat (%) used to derive lean mass (kg) based on total body mass (kg)	Change from pre (day 1) to post intervention (day 18)
Secondary	Blood pressure	Assessment of systolic and diastolic blood pressure (measured in mmHg) at rest	Change from pre (day 1) to post intervention (day 18)